Xenetic Biosciences, Inc.
XBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,166 | $8,983 | $13,097 | $18,244 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $422 | $604 | $556 | $479 |
| Total Curr. Assets | $6,588 | $9,587 | $13,653 | $18,723 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $314 | $1,018 | $1,067 | $1,092 |
| Total NC Assets | $314 | $1,018 | $1,067 | $1,092 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,901 | $10,605 | $14,720 | $19,815 |
| Liabilities | – | – | – | – |
| Payables | $284 | $241 | $287 | $362 |
| Short-Term Debt | $0 | $0 | $0 | $27 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $611 | $569 | $786 | $1,032 |
| Total Curr. Liab. | $894 | $810 | $1,073 | $1,421 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $27 |
| Total Liabilities | $894 | $810 | $1,073 | $1,421 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $3 | $3 |
| Common Stock | $2 | $2 | $2 | $13 |
| Retained Earnings | -$197,194 | -$193,234 | -$189,100 | -$182,547 |
| AOCI | $254 | $254 | $254 | $254 |
| Other Equity | $202,945 | $202,773 | $202,489 | $200,672 |
| Total Equity | $6,007 | $9,796 | $13,647 | $18,394 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,901 | $10,605 | $14,720 | $19,815 |
| Net Debt | -$6,166 | -$8,983 | -$13,097 | -$18,217 |